The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study

BACKGROUND: The INPULSIS trials revealed that nintedanib reduced the decline in lung function in patients with idiopathic pulmonary fibrosis. We aimed to evaluate the efficacy and safety of nintedanib in Japanese idiopathic pulmonary fibrosis patients in real-world settings. METHOD: Medical records...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobashi, Masaki, Tanaka, Hisashi, Taima, Kageaki, Itoga, Masamichi, Ishioka, Yoshiko, Shiratori, Toshihiro, Okumura, Fumihiko, Tabe, Chiori, Tanaka, Yoshihito, Morimoto, Takeshi, Hasegawa, Yukihiro, Yasugahira, Hideo, Okudera, Koichi, Takanashi, Shingo, Tasaka, Sadatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188975/
https://www.ncbi.nlm.nih.gov/pubmed/34164129
http://dx.doi.org/10.1177/20503121211023357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188975/
https://www.ncbi.nlm.nih.gov/pubmed/34164129
http://dx.doi.org/10.1177/20503121211023357

Ejemplares similares